8 ways 3D printing is making surgery remarkable

3D printing is already making a difference in healthcare: It enables models of organs to train surgeons and educate patients –and improve surgical outcomes. Doctors previously had to examine actual organs with their hands to get a feel for what they need to do surgically. Now, MRIs and 3D printers eliminate the need to put

Pages: 1 2 3 4 5 6 7 8 9

Zeiss touts new imaging software

The new Zeiss Zen 2 core imaging software is a lab infrastructure booster that connects systems, data and workflows, according to its creator Zeiss. The software reflects multi-modal workflows in connected lab environments with a single general user interface, according to Zeiss. The company says the result is a boost in efficiency through interactive control of

Medtech stories we missed this week: July 14, 2017

From Novarad touting its VR-surgical guidance system to Zynex paying off its $2.2M loan, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Stimwave announces first patient in Brazil Stimwave announced in a July 5 press release that its first patients in Brazil have received Stimwave’s wireless pain relief

Biocompatible 3D tracking could improve surgeries

Johns Hopkins University researchers recently wowed with their smart tissue, autonomous robot (STAR). It turns out the STAR’s biocompatible, near-infrared 3D tracking system is innovative, too. The tracking system – which uses near-infrared fluorescent (NIRF) markers – could improve both manual and robot-assisted surgery and interventions, according to a new study. The study compared the 3D tracking

Agilent Tech pays $52m for Raman spectroscopy developer Cobalt

Agilent Technologies said today it’s acquired U.K.-based Raman spectroscopic instrument developer Cobalt Light Systems for $51.5 million (GBP £40 million). Cobalt develops benchtop and handheld Raman spectroscopic instruments based on proprietary technologies to enable through-barrier identification of chemicals and materials, the company said. “Raman spectroscopy is one of the fastest-growing segments in spectroscopy. This acquisition

Neuroimaging could be the key to early autism diagnoses

Functional connectivity magnetic resonance imaging (fcMRI) may be able to predict the chances of developing autism by the age of 2 in high-risk 6-month old infants, according to a new study in the Science Translational Medicine journal. Autism is characterized by challenges in social skills, repetitive behaviors, speech and nonverbal communication. People with autism also

Fujifilm receives authority to operate on government networks

Fujifilm Medical Systems has announced that its Synapse PACS medical imaging and information management system has officially received Authority to Operate (ATO) on Department of Defense (DoD) networks in the U.S. The ATO makes Fujifilm the first company with a networked medical system to gain Risk Management Framework-based ATO. “This particular ATO is an unprecedented

Handheld device scans beneath skin for psoriasis evaluation

A new handheld tissue scanner could eliminate the need for contrast agents or radiation exposure when looking under the skin in psoriasis patients, thanks to researchers at Helmholtz Zentrum München and the Technical University of Munich. The new tissue scanner can give clinicians important information about the skin like the structure of skin layers and

DoubleBlack Imaging buys Richardson Healthcare’s PACS imaging display biz

Richardson Electronics said last week it is selling its picture archiving and communications systems display business, including its Image Systems brand, to Double Black Imaging for an undisclosed amount. The Image Systems portfolio includes 2MP through 6MP color and grayscale displays as well as proprietary CFS calibration software designed to simplify conformance and calibration of

Why X-rays in shoe stores were a really bad idea

Vanessa Burrows, FDA historian X-rays have enhanced healthcare in a variety of ways since their discovery in the late 19th century. But like many cutting-edge scientific developments, the technology has also inspired uses of uncertain therapeutic value. That was the case with the shoe-fitting fluoroscope, the subject of the latest episode of FDA’s history video

Endra Life Sciences IPO to raise $8.4 million

Endra Life Sciences’s IPO offering, which closes tomorrow, is expected to raise $8.4 million as the company seeks to commercialize its Thermo Acoustic Enhanced Ultrasound (TAEUS) in Europe. Endra announced May 9 that the IPO would involve 1.68 million units – each including one share of common stock and a warrant to purchase an additional share of

B. Braun Medical to bring Christie Medical’s VeinViewer to more hospitals

Christie Medical Holdings, with its vein-finding VeinViewer system, has announced a strategic alliance with B. Braun Medical, a major player in infusion therapy and pain management. “Aligning the VeinViewer technology with one of the top companies in the United States’s peripheral IV catheter market provides our customers with a seamless solution for improving peripheral IV access,” said

This test can detect tiny ovarian tumors sooner than current tests

Massachusetts Institute of Technology engineers have developed a way to detect ovarian tumors that are smaller than 2 mm in diameter, allowing for detection 5 months earlier than existing tests. A synthetic biomarker, which is a nanoparticle that works with tumor proteins to release fragments into the urine for detection, helps the MIT-developed test create

Philips’ digitized biopsied tissue slides wins FDA authorization

Philips recently received FDA permission to market its Philips IntelliSite Pathology Solution (PIPS) – touted as the first whole slide imaging system over which pathologists can review digital versions slides prepared from biopsied tissue. The FDA permission, which the agency announced April 12, marks the first time the agency has allowed the marketing of a

How deep learning could change diagnostic imaging forever

Computational imaging is a passion for Fabein Beckers. As the CEO of Arterys, Beckers thinks he can revolutionize how doctors on a global scale work with imaging diagnostics. In that vein, Beckers and his team launched Arterys, which enables clinical visualization and accurate quantification of blood flow inside the body. It measures 7 dimensions of data (3 in